{"id":29633,"date":"2026-03-11T01:00:00","date_gmt":"2026-03-11T00:00:00","guid":{"rendered":"https:\/\/staging2.brillpharma.com\/?p=29633"},"modified":"2026-05-02T13:21:33","modified_gmt":"2026-05-02T11:21:33","slug":"holanda-se-suma-al-mapa-internacional-de-brill-pharma","status":"publish","type":"post","link":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/holanda-se-suma-al-mapa-internacional-de-brill-pharma\/","title":{"rendered":"Holanda se suma al mapa internacional de Brill Pharma"},"content":{"rendered":"\n<h2 class=\"wp-block-heading has-medium-font-size\">Brill Pharma impulsa su expansi\u00f3n internacional con la entrada en el mercado holand\u00e9s mediante un acuerdo con Tramedico para la distribuci\u00f3n de Matrix Ocular\u00ae 3.<\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"370\" src=\"https:\/\/staging2.brillpharma.com\/wp-content\/uploads\/2026\/04\/holanda-copia-1024x370.jpg\" alt=\"\" class=\"wp-image-29634\" srcset=\"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/wp-content\/uploads\/2026\/04\/holanda-copia-1024x370.jpg 1024w, https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/wp-content\/uploads\/2026\/04\/holanda-copia-300x108.jpg 300w, https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/wp-content\/uploads\/2026\/04\/holanda-copia-768x277.jpg 768w, https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/wp-content\/uploads\/2026\/04\/holanda-copia.jpg 1417w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Brill Pharma sigue consolidando su crecimiento internacional con la incorporaci\u00f3n de&nbsp;<strong>Holanda a su red global de mercados<\/strong>, en el marco de su estrategia de expansi\u00f3n en el \u00e1mbito de la Oftalmolog\u00eda.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">En este contexto, el pasado mes de enero la compa\u00f1\u00eda alcanz\u00f3 un acuerdo con&nbsp;<strong>Tramedico<\/strong>&nbsp;para la distribuci\u00f3n de&nbsp;<strong>Matrix Ocular\u00ae 3<\/strong>&nbsp;en el mercado holand\u00e9s, marcando un nuevo hito en su desarrollo internacional.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La llegada de Matrix Ocular\u00ae 3 a Holanda \u2014y pr\u00f3ximamente a otros pa\u00edses\u2014 refuerza el compromiso de Brill Pharma con el&nbsp;<strong>avance del cuidado oftalmol\u00f3gico a nivel global<\/strong>, acercando soluciones innovadoras a profesionales sanitarios y pacientes en nuevos mercados.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Este acuerdo se suma a otras colaboraciones ya consolidadas en distintos pa\u00edses, como la distribuci\u00f3n de&nbsp;<strong>Matrix Ocular\u00ae 3 en Marruecos<\/strong>,&nbsp;<strong>Ocudox en Italia<\/strong>&nbsp;o el&nbsp;<strong>Estesi\u00f3metro Corneal Brill<\/strong>&nbsp;en mercados asi\u00e1ticos como&nbsp;<strong>Singapur, China y Jap\u00f3n<\/strong>, ampliando progresivamente la presencia internacional de la compa\u00f1\u00eda.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A trav\u00e9s de productos innovadores como&nbsp;<strong>Matrix Ocular\u00ae 3<\/strong>&nbsp;y herramientas diagn\u00f3sticas de \u00faltima generaci\u00f3n como el&nbsp;<strong>Estesi\u00f3metro Corneal Brill<\/strong>, la compa\u00f1\u00eda trabaja para&nbsp;<strong>mejorar la salud ocular de las personas<\/strong>, facilitando la pr\u00e1ctica cl\u00ednica y promoviendo la detecci\u00f3n temprana y el manejo eficaz de las enfermedades de la superficie ocular.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Brill Pharma impulsa su expansi\u00f3n internacional con la entrada en el mercado holand\u00e9s mediante un acuerdo con Tramedico para la distribuci\u00f3n de Matrix Ocular\u00ae 3.<\/p>\n","protected":false},"author":69,"featured_media":29829,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[4],"tags":[],"class_list":["post-29633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/posts\/29633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/users\/69"}],"replies":[{"embeddable":true,"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/comments?post=29633"}],"version-history":[{"count":2,"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/posts\/29633\/revisions"}],"predecessor-version":[{"id":29658,"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/posts\/29633\/revisions\/29658"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/media\/29829"}],"wp:attachment":[{"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/media?parent=29633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/categories?post=29633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/global-f2af4a.bp.sta01.doubleyou.com\/es\/wp-json\/wp\/v2\/tags?post=29633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}